Nerve side effects
Why chemotherapy may be reduced for numbness
Because nerve damage from certain drugs builds with each dose and, once severe, is more likely to last. When numbness or nerve pain starts to affect daily life, your oncologist may lower the dose, space cycles, pause or switch the drug. It is a shared trade-off between treating the cancer and protecting your hands and feet.
The short answer
Why might chemotherapy be reduced because of numbness?
Because nerve damage from certain drugs builds with each dose, and once it becomes severe it is more likely to be lasting. When numbness, tingling or nerve pain start to interfere with daily life, your oncologist may lower the dose, space the cycles further apart, pause the drug, or swap it for another. The aim is to keep treating the cancer effectively while protecting your ability to use your hands and walk safely for the rest of your life.
It is a trade-off, and patients are entitled to understand it. Many worry that any reduction means the treatment will not work. Oncologists adjust doses for side effects routinely, and they weigh any change against what the treatment is trying to achieve. Talking it through openly is far better than hiding symptoms to avoid a change.
The decision is shared
Your oncologist explains the options and the likely effects; you explain how the symptoms affect your life and what matters most to you.
Timing matters
Adjustments made while symptoms are mild protect the nerves best. Waiting until severe damage has developed removes much of that benefit.
Ask what a change means for the aim of treatment
That single question usually makes the decision much clearer, and the answer is often more reassuring than patients expect.
Never reduce, skip or stop tablets yourself because of numbness. Discuss it with your team first.The options
What your oncologist may consider
- Lowering the dose
- Giving a smaller amount of the drug that affects the nerves, while keeping the rest of the treatment the same. A common first step when symptoms are becoming noticeable.
- Spacing cycles further apart
- Allowing more time between doses so the nerves are under less continuous pressure. This may lengthen the overall course.
- Pausing the drug
- Stopping the nerve-affecting drug for one or more cycles and restarting when symptoms improve, sometimes at a lower dose.
- Stopping that drug and continuing others
- Where a regimen has several drugs, the one causing nerve damage may be stopped while the others continue.
- Switching to a different drug
- Replacing the drug with another that is less likely to affect the nerves, where a suitable alternative exists for your cancer.
- Continuing unchanged, with close monitoring
- Sometimes, particularly when treatment is near its end or the benefit is especially important, the team and patient agree to continue and watch closely.
Not sure whether this applies to you?
Ask an oncologistPractical
Having the conversation with your team
Clear information on both sides makes a better decision.
Describe what the symptoms stop you doing
Buttons, writing, cooking, walking, working, playing an instrument, feeling the ground. Function tells your team more than a description of the feeling alone.
Mention especially
- Anything affecting work or safety
- Falls or near-falls
Ask what each option means
For each possible change, ask how it might affect the treatment's aim and how it might affect your nerves. Ask for the answer in plain words.
Say what matters most to you
For a tailor, musician, farmer or surgeon, hand function may be central to life and livelihood. For others, walking safely or independence matters most. It is a legitimate part of the decision.
Useful to say
- What you most want to protect
- What you are most worried about
Bring someone with you
A relative can help remember what was said and add what they have noticed at home, such as dropped objects or unsteadiness.
Ask when it will be reviewed
Dose changes are usually reassessed at each cycle. Ask how the team will decide whether to restore the dose, keep it lower, or change the plan again.
Sudden weakness of an arm, leg or one side of the face · numbness spreading quickly over hours or a day or two · loss of control of the bladder or bowels · new severe back pain with leg numbness or weakness · a fall with a head injury · a wound on a numb foot that is red, hot, swollen or discharging, especially with fever. Go to the nearest emergency department and say clearly that the person is on chemotherapy.
Being straight with you
What this page cannot tell you
It cannot tell you whether a dose change will affect how well your own treatment works. That depends on your cancer type, its stage, what the treatment aims to achieve, how well it is working, and how much of the course remains. Only your oncologist can weigh those together.
It also cannot tell you which option is right. The same symptoms might lead to a dose reduction for one patient and continued treatment for another, depending on their situation and priorities.
Hiding symptoms makes the decision worse
Patients who conceal numbness to avoid a change often end up with severe damage that forces a larger change later, or lasting problems that could have been avoided. Honest reporting gives you and your team the best choices.
A reduction is not a failure
Dose adjustments for side effects are a routine part of chemotherapy. They reflect good care, not a treatment going wrong.
Near the end of a course, the balance changes
With only one or two cycles left, the options and their consequences differ. Ask specifically what stopping or reducing would mean at that stage.
You can ask for time to think
Unless the situation is urgent, it is reasonable to take a day to consider the options with your family before deciding, as long as treatment is not delayed without discussion.
What to do next
Before your next cycle, tell your team exactly what the numbness stops you doing. Ask what each possible change would mean for the aim of your treatment and for your nerves, say what matters most to you, bring a relative, and ask how the decision will be reviewed.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Four fears about lowering the dose
Doses are adjusted routinely, and your oncologist weighs any change against the aim of treatment. Ask what a change means for you rather than assuming the worst.
Hidden symptoms often become severe, forcing a bigger change later and leaving lasting damage. Honest reporting gives the best options.
This is a shared decision. Your oncologist should explain the options, and your priorities about hand function, walking and work are part of it.
Never change your dose alone. Report symptoms and let your team adjust treatment safely.
Questions we are asked
Common questions about dose changes for nerve damage
Why would my dose be reduced?
To limit nerve damage that is building up from certain drugs. Adjusting while symptoms are mild protects the nerves best while still treating the cancer.
Will a lower dose make treatment less effective?
Not necessarily. Your oncologist considers the aim of treatment, how well it is working and how much remains. Ask directly what a change would mean for you.
What other options are there?
Spacing cycles, pausing the drug, stopping just the nerve-affecting drug, switching to another drug, or continuing with close monitoring. The right choice depends on your situation.
Can the dose be increased again later?
Sometimes, if symptoms improve. Your team reassesses at each cycle and will explain whether restoring the dose is reasonable.
What should I tell my doctor?
Where the numbness is, whether it settles between cycles, what it stops you doing, whether it hurts, and what matters most to you, such as work or walking safely.
Is it my choice?
It is a shared decision. Your oncologist advises on what is medically sound, and your priorities help decide between reasonable options.
What if I only have one cycle left?
The balance may be different near the end. Ask your oncologist what stopping, reducing or continuing would mean at that stage for both your cancer and your nerves.
Can I reduce my tablets myself?
No. Never change a dose on your own. Report symptoms to your team, who can adjust treatment safely.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- National Cancer Institute — Chemotherapy and You: Support for People With Cancer
- Cancer Research UK — Side effects of chemotherapy
- Macmillan Cancer Support — Chemotherapy
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Discussing a change to your treatment?
Tell us what has been found so far and we will help you reach the right specialist. One helpline serves every CION centre.